Pfizer Offered $99 Billion In AstraZeneca Bid - Presented by: The Aol. On Network

Pfizer confirmed today that it had asked AstraZeneca to consider a merger, and been rebuffed. Under U.K. law, it had to disclose the offer and went public with a $98.7 billion offer to buy the London-based drug maker. The deal will be 70% cash and 30% stock, and will provide Pfizer with a way to use funds it has kept out of the U.S. without paying U.S. taxes. The deal would also allow Pfizer to lower its tax rate by creating a holding company in the U.K.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 15.81 0.23 ▼ 1.43%
JCP $ 8.50 0.62 ▼ 6.80%
AAPL $ 128.46 1.96 ▼ 1.50%
GE $ 25.99 0.10 ▲ 0.39%
S $ 5.12 0.35 ▲ 7.34%
PBR $ 6.63 0.34 ▲ 5.41%
CHK $ 16.68 0.52 ▼ 3.02%
TVIX $ 2.08 unch

As of 2/27/2015, 04:15 PM
More Most Active